| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 126, 891-898, Copyright © 1990 by Endocrine Society
ARTICLES |
BS Katzenellenbogen and MJ Norman
Department of Physiology and Biophysics, University of Illinois, Urbana 61801.
Estrogen (E) is well known to be an important stimulator of progesterone receptor (PR) synthesis in target cells. We have observed that E stimulation of PR in MCF-7 human breast cancer cells (as monitored by progestin binding or Western blotting with anti-PR antibodies) increases as a function of serum concentration in the cell culture medium; PR stimulation by E is greatest in high serum medium (5% or 10% charcoal dextran-treated calf serum) and is not observed when cells are in medium containing serum concentrations below 1%, although estrogen receptor levels are well maintained. This suggests that some serum factor(s) may be essential for E to be able to stimulate PR. To better understand such factors, we have grown cells in serum-free medium and in serum-free medium supplemented with insulin (6.25 micrograms/ml) [corrected], transferrin (6.25 micrograms/ml), selenium (6.25 ng/ml), albumin (1.25 mg/ml) [corrected], and linoleic acid (5.35 micrograms/ml; ITS+). Unexpectedly, we found that addition of ITS+ (without E) increases PR levels in these cells, especially in the absence of serum and under low serum conditions where E stimulation of PR is poor. Analyses of the individual components in ITS+ reveal that insulin is the major active component. Dose-response studies indicate that high superphysiological (greater than 1 microgram/ml) concentrations of insulin are required. In contrast, low physiological levels of insulin-like growth factor-I (IGF-I; 10 or 40 ng/ml) are active, suggesting mediation by the IGF type I receptor system. At all serum concentrations (0-10%), the effects of ITS+ and E in increasing PR are synergistic. The fact that anti-E are able to suppress the insulin/IGF-I stimulation as well as the E stimulation of PR suggests that the anti-E can actively interfere with the action of the growth factor as well as the action of E. These results indicate that regulation of PR is multifactor and raise the possibility that PR may be regulated in vivo by both E and growth factors such as IGF-I that are known to be increased in these breast cancer cells by E.
This article has been cited by other articles:
 |
|
 |
|
  A. R. Daniel, E. J. Faivre, and C. A. Lange Phosphorylation-Dependent Antagonism of Sumoylation Derepresses Progesterone Receptor Action in Breast Cancer Cells Mol. Endocrinol., December 1, 2007; 21(12): 2890 - 2906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Zhang, X Li, R Burghardt, R Smith III, and S H Safe Role of estrogen receptor (ER) {alpha} in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells J. Mol. Endocrinol., December 1, 2005; 35(3): 433 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Banerjee, K. Sengupta, N. K. Saxena, K. Dhar, and S. K. Banerjee Epidermal Growth Factor Induces WISP-2/CCN5 Expression in Estrogen Receptor-{alpha}-Positive Breast Tumor Cells through Multiple Molecular Cross-talks Mol. Cancer Res., March 1, 2005; 3(3): 151 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rodriguez-Cuenca, M. Monjo, A. M. Proenza, and P. Roca Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E200 - E207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Maruo, N. Ohara, J. Wang, and H. Matsuo Sex steroidal regulation of uterine leiomyoma growth and apoptosis Hum. Reprod. Update, May 1, 2004; 10(3): 207 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamada, S. Nakago, O. Kurachi, J. Wang, S. Takekida, H. Matsuo, and T. Maruo Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells Hum. Reprod., April 1, 2004; 19(4): 815 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Lobenhofer, L. Bennett, P. L. Cable, L. Li, P. R. Bushel, and C. A. Afshari Regulation of DNA Replication Fork Genes by 17{beta}-Estradiol Mol. Endocrinol., June 1, 2002; 16(6): 1215 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Gao, H. Matsuo, Y. Wang, S. Nakago, and T. Maruo Up-Regulation by IGF-I of Proliferating Cell Nuclear Antigen and Bcl-2 Protein Expression in Human Uterine Leiomyoma Cells J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5593 - 5599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Greenberger, T. Annable, K. I. Collins, B. S. Komm, C. R. Lyttle, C. P. Miller, P. G. Satyaswaroop, Y. Zhang, and P. Frost A New Antiestrogen, 2-(4-Hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), Inhibits the Growth of Tamoxifen-sensitive and -resistant Tumors and Is Devoid of Uterotropic Effects in Mice and Rats Clin. Cancer Res., October 1, 2001; 7(10): 3166 - 3177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Oh, L. A. Lorant, J. N. Holloway, D. L. Miller, F. G. Kern, and D. El-Ashry Hyperactivation of MAPK Induces Loss of ER{alpha} Expression in Breast Cancer Cells Mol. Endocrinol., August 1, 2001; 15(8): 1344 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Wood, V. S. Likhite, M. A. Loven, and A. M. Nardulli Allosteric Modulation of Estrogen Receptor Conformation by Different Estrogen Response Elements Mol. Endocrinol., July 1, 2001; 15(7): 1114 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lee, F. Jiang, Q. Wang, S. V. Nicosia, J. Yang, B. Su, and W. Bai MEKK1 Activation of Human Estrogen Receptor {alpha} and Stimulation of the Agonistic Activity of 4-Hydroxytamoxifen in Endometrial and Ovarian Cancer Cells Mol. Endocrinol., November 1, 2000; 14(11): 1882 - 1896. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. L. Woodward, J. Xie, J. L. Fendrick, and S. Z. Haslam Proliferation of Mouse Mammary Epithelial Cells in Vitro: Interactions among Epidermal Growth Factor, Insulin-Like Growth Factor I, Ovarian Hormones, and Extracellular Matrix Proteins Endocrinology, October 1, 2000; 141(10): 3578 - 3586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Woodward, H. Lu, and S. Z. Haslam Laminin Inhibits Estrogen Action in Human Breast Cancer Cells Endocrinology, August 1, 2000; 141(8): 2814 - 2821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. N. Petz and A. M. Nardulli Sp1 Binding Sites and An Estrogen Response Element Half-Site Are Involved in Regulation of the Human Progesterone Receptor A Promoter Mol. Endocrinol., July 1, 2000; 14(7): 972 - 985. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. E. Favoni and A. De Cupis The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach Pharmacol. Rev., June 1, 2000; 52(2): 179 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Zeps, J. M. Bentel, J. M. Papadimitriou, and H. J.S. Dawkins Murine Progesterone Receptor Expression in Proliferating Mammary Epithelial Cells During Normal Pubertal Development and Adult Estrous Cycle: Association with ER{alpha} and ER{beta} Status J. Histochem. Cytochem., October 1, 1999; 47(10): 1323 - 1330. [Abstract] [Full Text]
|
|
|
|
|
|
P. A. Mote, R. L. Balleine, E. M. McGowan, and C. L. Clarke Colocalization of Progesterone Receptors A and B by Dual Immunofluorescent Histochemistry in Human Endometrium during the Menstrual Cycle J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2963 - 2971. [Abstract] [Full Text]
|
|
|
|
|
|
P. V. N. Bodine, H. A. Harris, and B. S. Komm Suppression of Ligand-Dependent Estrogen Receptor Activity by Bone-Resorbing Cytokines in Human Osteoblasts Endocrinology, June 1, 1999; 140(6): 2439 - 2451. [Abstract] [Full Text]
|
|
|
|
|
|
A. V. Lee, J. G. Jackson, J. L. Gooch, S. G. Hilsenbeck, E. Coronado-Heinsohn, C. K. Osborne, and D. Yee Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo Mol. Endocrinol., May 1, 1999; 13(5): 787 - 796. [Abstract] [Full Text]
|
|
|
|
|
|
J. Nakamura, Q. Lu, G. Aberdeen, E. Albrecht, and A. Brodie The Effect of Estrogen on Aromatase and Vascular Endothelial Growth Factor Messenger Ribonucleic Acid in the Normal Nonhuman Primate Mammary Gland J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1432 - 1437. [Abstract] [Full Text]
|
|
|
|
|
|
S. Migliaccio, T. F. Washburn, S. Fillo, H. Rivera, A. Teti, K. S. Korach, and W. C. Wetsel Modulation of Estrogen Receptor Levels in Mouse Uterus by Protein Kinase C Isoenzymes Endocrinology, November 1, 1998; 139(11): 4598 - 4606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Philips, C. Teyssier, F. Galtier, C. Rivier-Covas, J.-M. Rey, H. Rochefort, and D. Chalbos FRA-1 Expression Level Modulates Regulation of Activator Protein-1 Activity by Estradiol in Breast Cancer Cells Mol. Endocrinol., July 1, 1998; 12(7): 973 - 985. [Abstract] [Full Text]
|
|
|
|
|
|
G. Freiss, C. Puech, and F. Vignon Extinction of Insulin-Like Growth Factor-I Mitogenic Signaling by Antiestrogen-Stimulated Fas-Associated Protein Tyrosine Phosphatase-1 in Human Breast Cancer Cells Mol. Endocrinol., April 1, 1998; 12(4): 568 - 579. [Abstract] [Full Text]
|
|
|
|
 |
|
 W. Bai, B. G. Rowan, V. E. Allgood, B. W. O'Malley, and N. L. Weigel Differential Phosphorylation of Chicken Progesterone Receptor in Hormone-dependent and Ligand-independent Activation J. Biol. Chem., April 18, 1997; 272(16): 10457 - 10463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Byers, G. G. J. M. Kuiper, J.-A. Gustafsson, and O.-K. Park-Sarge Estrogen Receptor-{beta} mRNA Expression in Rat Ovary: Down-Regulation by Gonadotropins Mol. Endocrinol., February 1, 1997; 11(2): 172 - 182. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Mani, J. Allen, J. Clark, J. Blaustein, and B. O'Malley Convergent pathways for steroid hormone- and neurotransmitter-induced rat sexual behavior Science, August 26, 1994; 265(5176): 1246 - 1249. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
